Medable Secures $91 Million Funding to Accelerate Industry Shift to Digital and Decentralized Clinical Trials
Nov 19, 2020•over 4 years ago
Amount Raised
$91 Million
Description
Medable Inc. today announced $91 million in new funding to accelerate the life sciences industry’s shift to digital and decentralized clinical trials. The Series C funding round was led by Sapphire Ventures, with follow-on investment from existing investors GSR Ventures, PPD, Inc. (Nasdaq:PPD) and Streamlined Ventures
FundzWatch™ Score
72
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech